N, H., M, Y., K, B., M, F., & D, P. (2021). Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients. Cancer chemotherapy and pharmacology, 88(3), 533. https://doi.org/10.1007/s00280-021-04307-0
Chicago Style (17th ed.) CitationN, Helsby, Yong M, Burns K, Findlay M, and Porter D. "Cyclophosphamide Bioactivation Pharmacogenetics in Breast Cancer Patients." Cancer Chemotherapy and Pharmacology 88, no. 3 (2021): 533. https://doi.org/10.1007/s00280-021-04307-0.
MLA (9th ed.) CitationN, Helsby, et al. "Cyclophosphamide Bioactivation Pharmacogenetics in Breast Cancer Patients." Cancer Chemotherapy and Pharmacology, vol. 88, no. 3, 2021, p. 533, https://doi.org/10.1007/s00280-021-04307-0.
Warning: These citations may not always be 100% accurate.